SIMPLIFIED HEPARIN THERAPY OF IMPENDING AND ACUTE MYOCARDIAL INFARCTION
Authors: H ENGELBERG
Journal: Annals of Internal Medicine (1956)

Article1 March 1956SIMPLIFIED HEPARIN THERAPY OF IMPENDING AND ACUTE MYOCARDIAL INFARCTIONHYMAN ENGELBERG, M.D.HYMAN ENGELBERG, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-44-3-466 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIt is now recognized that premonitory symptoms occur in a substantial proportion of all attacks of acute myocardial infarction.1There is a definite change in the clinical picture, with increasingly severe angina and rapidly decreasing effort tolerance. The electrocardiogram at rest may or may not indicate coronary insufficiency, and it is not as important as the clinical story in the diagnosis. This is particularly true when the patient has been under the physician's care for a considerable time. Nevertheless, the diagnosis of impending coronary occlusion cannot be established with absolute certainty unless an infarction actually occurs. It is most apt...Bibliography1. Feil H: Preliminary pain in coronary thrombosis, Am. J. M. Sc. 193: 42-49, 1937. CrossrefGoogle Scholar2. WrightBourgainFoleyMcDevittGrossBurkeSimonLiebermanSymonsHuebner ISRHWTECGEJCR: Long term anticoagulant therapy, Circulation 9: 748-757 (May) 1954. CrossrefMedlineGoogle Scholar3. NicholPhillipsJenkins ESWCVE: Anticoagulants in coronary heart disease, M. Clin. North America 38: 399-412 (March) 1954. CrossrefGoogle Scholar4. SmithPapp KSC: The prevention of impending cardiac infarction by anticoagulant treatment, Brit. Heart J. 13: 467-472 (Oct.) 1951. CrossrefMedlineGoogle Scholar5. Engelberg H: Prolonged anticoagulant therapy with subcutaneously administered concentrated aqueous heparin, Surgery 36: 762-770 (Oct.) 1954. MedlineGoogle Scholar6. ArtzAmspacher CPWH: Evaluation of various methods of administration of heparin, Surgical Forum of American College of Surgeons, 1952, W. B. Saunders Co., Philadelphia. Google Scholar7. MonkhouseMacMillanBrown FCRLKW: The relation between heparin blood levels and blood coagulation times, J. Lab. and Clin. Med. 42: 92-97 (July) 1953. MedlineGoogle Scholar8. Jorpes JE: The origin and physiology of heparin: the specific therapy in thrombosis, Ann. Int. Med. 27: 361, 1947. LinkGoogle Scholar9. Bauer G: Nine years' experience with heparin in acute venous thrombosis, Angiology 1: 161, 1950. CrossrefMedlineGoogle Scholar10. D'Alessandro AJ: Venous thrombosis. The problem and its management, Am. J. Surg. 85: 652, 1953. CrossrefMedlineGoogle Scholar11. Brown A: Anticoagulants and anticoagulant therapy: a review, Glasgow M. J. 33: 225, 1952. MedlineGoogle Scholar12. De Takats G: Anticoagulant therapy, Surgery 34: 985-1004 (Dec.) 1953. MedlineGoogle Scholar13. LoeweHirschGrayzelKashdon LEDMF: Experimental study of the comparative action of heparin and Dicumarol on the in vivo clot, J. Lab. and Clin. Med. 33: 721-732, 1948. MedlineGoogle Scholar14. KiesewetterShumacker WBHB: An experimental study of the comparative efficacy of heparin and Dicumarol in the prevention of arterial and venous thrombosis, Surg., Gynec. and Obst. 86: 689-702, 1948. Google Scholar15. Wessler SL: Studies in intravascular coagulation. II. A comparison of the effect of Dicumarol and heparin on clot formation in isolated venous segments, J. Clin. Investigation 32: 650-654 (July) 1953. CrossrefMedlineGoogle Scholar16. Wessler SL: SPCA induced thrombosis: its pathogenesis and the effect of anticoagulants, presented at Second World Congress of Cardiology, Washington, D. C., September, 1954. Google Scholar17. Schneider RA: Relative viscosity and clotting time of whole blood in the healthy and in those with vascular disorders, J. Clin. Investigation 30: 672-676, 1951. Google Scholar18. HurwitzYesnerCooke ARRW: Ultrasonic measurements of the effect of heparin on blood viscosity, Lab. Investigation 1: 463, 1952. MedlineGoogle Scholar19. MooltenVromanVroman SELGM: Adhesiveness of blood platelets in thromboembolism and hemorrhagic disorders, Am. J. Clin. Path. 19: 814-826, 1949. CrossrefMedlineGoogle Scholar20. Hahn PF: Abolishment of alimentary lipemia following injection of heparin, Science 98: 19, 1943. CrossrefMedlineGoogle Scholar21. GrahamLyonGofmanJonesYankleySimontonWhite DMTPJWHBAJS: Blood lipids and human atherosclerosis. II. The influences of heparin upon lipoprotein metabolism, Circulation 4: 666-673 (Nov.) 1951. CrossrefMedlineGoogle Scholar22. FullertonDavieAnastasopoulos HWWJG: Relationship of alimentary lipemia to blood coagulability, Brit. M. J. 2: 250-253 (Aug. 1) 1953. CrossrefMedlineGoogle Scholar23. LoughryCole CWJW: In vitro effect of autologous lipemia plasma on platelet suspensions, Proc. Soc. Exper. Biol. and Med. 85: 631-632 (Apr.) 1954. CrossrefMedlineGoogle Scholar24. Swank RL: Effect of high fat feedings on viscosity of the blood, Science 120: 427-428 (Sept. 10) 1954. CrossrefMedlineGoogle Scholar25. CullenSwank CFRL: Intravascular aggregation and adhesiveness of the blood elements associated with alimentary lipemia and injections of large molecular substances, Circulation 9: 335-346 (Mar.) 1954. CrossrefMedlineGoogle Scholar26. KuoJoyner PTCR: The effect of alimentary lipemia on angina pectoris and circulatory dynamics of patients with coronary artery disease, presented at Second World Congress of Cardiology, Washington, D. C., September, 1954. Google Scholar27. Engelberg H: Heparin therapy of severe coronary atherosclerosis with observations of its effect on angina pectoris, the two-step electrocardiogram and the ballistocardiogram, Am. J. M. Sc. 224: 487, 1952. CrossrefMedlineGoogle Scholar28. MartinHueper GJWC: Biochemical studies of atheromatous animals, Proc. Soc. Exper. Biol. and Med. 49: 452-455, 1942. CrossrefGoogle Scholar29. EngelbergKuhn HR: Studies of forearm arterio-venous oxygen differences in atherosclerotic patients before and after heparin, Circulation 10: 604 (Oct.) 1954, and to be published. Google Scholar30. GeigerLoewi ED: Versuche über die Glucosepermeabilität du Leber, Pflüger's Arch. f. d. ges. Physiol. 198: 633, 1923. CrossrefGoogle Scholar31. Bornstein J: Insulin reversible inhibition of glucose utilization by serum lipoprotein fractions, J. Biol. Chem. 205: 513, 1953. CrossrefMedlineGoogle Scholar32. Morrione TJ: The formation of collagen fibers by the action of heparin on soluble collagen: an electron microscope study, J. Exper. Med. 96: 107, 1952. CrossrefMedlineGoogle Scholar33. LuisadaContro AAS: Experimental pulmonary edema following rapid carotid infusion: mechanism and therapy, Circul. Res. 1: 179-183 (Mar.) 1953. CrossrefMedlineGoogle Scholar34. Littman D: The prevention of thromboembolism in acute coronary artery disease, New England J. Med. 247: 205 (Aug. 7) 1952. CrossrefMedlineGoogle Scholar35. RussekZohmanRussekWhiteDoermer HIBLASLGAA: Indications for bishydroxycoumarin (Dicumarol) in acute myocardial infarction, Circulation 5: 707, 1952. CrossrefMedlineGoogle Scholar36. Schnur S: Mortality and other studies questioning the evidence for and the value of routine anticoagulant therapy in acute myocardial infarction, Circulation 7: 855-868 (June) 1953. CrossrefMedlineGoogle Scholar37. FurmanBallGaleBillingsMeneely RHCORGFTGR: An evaluation of anticoagulant therapy in myocardial infarction based on prognostic categories, Am. J. Med. 14: 681, 1953. CrossrefMedlineGoogle Scholar38. Wright IS: An evaluation of anticoagulant therapy, Am. J. Med. 14: 720, 1953. CrossrefMedlineGoogle Scholar39. HalpernLembergBelleEichert MMLMH: The selective use of anticoagulants in acute myocardial infarction based on initial prognosis, Ann. Int. Med. 41: 942-951 (Nov.) 1954. LinkGoogle Scholar40. RussekZohman HIBL: Anticoagulant therapy in acute myocardial infarction. A survey of specialists' opinions concerning indications, results and dangers, Am. J. M. Sc. 225: 813 (June) 1953. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Beverly Hills, California*Received for publication May 13, 1955. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byComparison of continuous long-term heparin and oral anticoagulant therapy in patients with severe angina pectorisThe Use of Anticoagulants in Coronary Heart DiseaseDie Coronarerkrankungen. Coronarinsuffizienz, Angina pectoris und HerzinfarktLa période prémonitoire et la période finale de l'infarctus du myocardeChest Pain with Inverted T Waves, Predominantly in Precordial Leads, as the Only Electrocardiographic AbnormalityCardiac EmergenciesTHE FAILURE OF ANTICOAGULANT THERAPY TO PREVENT MYOCARDIAL INFARCTION IN PATIENTS WITH PREMONITORY SYMPTOMS OF AN IMPENDING CORONARY OCCLUSION*MILTON SCHLACHMAN, M.D., F.A.C.P.Anticoagulant therapy in coronary artery disease 1 March 1956Volume 44, Issue 3Page: 466-475KeywordsAnticoagulantsAttentionEdemaElectrocardiographyHemorrhageHeparinHyperlipidemiaInfarctionLaboratory testsMyocardial infarction ePublished: 1 December 2008 Issue Published: 1 March 1956 PDF downloadLoading ...